Are You Looking for a High-Growth Dividend Stock? — Positive
CADE Zacks Investment Research — July 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cadence (CADE) have what it takes?
Are You Looking for a High-Growth Dividend Stock? — Positive
CHCO Zacks Investment Research — July 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does City Holding (CHCO) have what it takes?
Zions (ZION) is a Top Dividend Stock Right Now: Should You Buy? — Positive
ZION Zacks Investment Research — July 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Zions (ZION) have what it takes?
Why Unitil (UTL) is a Great Dividend Stock Right Now — Positive
UTL Zacks Investment Research — July 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Unitil (UTL) have what it takes?
Why Banco Santander (SAN) is a Great Dividend Stock Right Now — Positive
SAN Zacks Investment Research — July 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Banco Santander (SAN) have what it takes?
DEADLINE ALERT: Holzer & Holzer, LLC Reminds Investors of August 11, 2025 Lead Plaintiff Deadline in the Rocket Pharmaceuticals, Inc. (RCKT) Class Action – Investors With Significant Losses Encouraged to Contact the Firm — Neutral
RCKT GlobeNewsWire — July 28, 2025ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to adequately disclose that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk.
Business First Bancshares, Inc. (BFST) Q2 2025 Earnings Call Transcript — Neutral
BFST Seeking Alpha — July 28, 2025Business First Bancshares, Inc. (NASDAQ:BFST ) Q2 2025 Earnings Conference Call July 28, 2025 10:00 AM ET Company Participants David R. Melville - Chairman, President & CEO Gregory Robertson - Executive VP, CFO & Treasurer Matthew Sealy - Corporate Participant Conference Call Participants Christopher William Marinac - Janney Montgomery Scott LLC, Research Division Feddie Justin Strickland - Hovde Group, LLC, Research Division Manuel Antonio Navas - D.A.
Coinbase investors should cash in. The stock has rallied too much ahead of earnings, analyst says. — Negative
COIN Market Watch — July 28, 2025If you bought Coinbase's stock two months ago when Monness Crespi Hardt analyst Gus Gala recommended it, you should take the profit now, he said.
3M's strong Q2 2025 results show robust sales, expanding margins, and impressive free cash flow conversion, supporting continued shareholder returns. The company has largely resolved major lawsuits, reducing legal overhang and positioning itself for future growth and stability. 3M's diversified business segments, especially safety and industrial, continue to deliver high margins and growth despite some weakness in consumer and electronics.
Warner Bros. Discovery Reveals Post-Split Leadership, Company Names — Neutral
WBD Deadline — July 28, 2025Warner Bros. Discovery unveiled some key details of its upcoming separation with leadership and the names of the two new companies. Streaming & Studios which will be home to Warner Bros. Television, Warner Bros. Motion Picture Group, DC Studios, HBO, HBO Max and Warner Bros.
GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval — Positive
GSK Seeking Alpha — July 28, 2025GSK's diversified portfolio and strong HIV/specialty medicines offer stability, but growth prospects remain modest amid stiff competition and legal overhangs. Despite a robust pipeline and management's long-term revenue targets, I see limited near-term catalysts to drive significant EPS or share price appreciation. Financials reveal rising inventories and a stretched balance sheet compared to peers, making the current valuation potentially a value trap.
Cloudflare to Post Q2 Earnings: Time to Buy, Sell or Hold the Stock? — Positive
NET Zacks Investment Research — July 28, 2025NET's second-quarter 2025 results are likely to benefit from AI adoption, growth of the Workers Developer platform and global expansion.
KLAC Set to Report Q4 Earnings: How Should You Play the Stock? — Positive
KLAC Zacks Investment Research — July 28, 2025KLA's Q4 results are likely to reflect gains from the advanced packaging surge and AI momentum, though tariffs and taxes weigh on margins.
Is the Options Market Predicting a Spike in Palomar Holdings Stock? — Neutral
PLMR Zacks Investment Research — July 28, 2025Investors need to pay close attention to Palomar Holdings stock based on the movements in the options market lately.
ASTH vs. CHE: Which Stock Is the Better Value Option? — Neutral
ASTH CHE Zacks Investment Research — July 28, 2025Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Astrana Health, Inc. (ASTH) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
YUMC or CMG: Which Is the Better Value Stock Right Now? — Positive
CMG YUMC Zacks Investment Research — July 28, 2025Investors with an interest in Retail - Restaurants stocks have likely encountered both Yum China Holdings (YUMC) and Chipotle Mexican Grill (CMG). But which of these two stocks presents investors with the better value opportunity right now?
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now? — Positive
AFYA LOPE Zacks Investment Research — July 28, 2025Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors?
LDOS vs. DT: Which Stock Is the Better Value Option? — Neutral
DT LDOS Zacks Investment Research — July 28, 2025Investors interested in stocks from the Computers - IT Services sector have probably already heard of Leidos (LDOS) and Dynatrace (DT). But which of these two stocks offers value investors a better bang for their buck right now?
ARI vs. LADR: Which Stock Should Value Investors Buy Now? — Positive
ARI LADR Zacks Investment Research — July 28, 2025Investors looking for stocks in the REIT and Equity Trust sector might want to consider either Apollo Commerical Finance (ARI) or Ladder Capital (LADR). But which of these two stocks is more attractive to value investors?
DRH or GLPI: Which Is the Better Value Stock Right Now? — Positive
DRH GLPI Zacks Investment Research — July 28, 2025Investors interested in REIT and Equity Trust - Other stocks are likely familiar with DiamondRock Hospitality (DRH) and Gaming and Leisure Properties (GLPI). But which of these two companies is the best option for those looking for undervalued stocks?